Drugs / Phoslax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02672293 | Jan 2013 → Apr 2018 | chronic kidney disease | Dr. Rachel Holden | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phoslax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02672293 ↗ |